brain concentrations fulminant hepatic failure BACKGROUND gamma-aminobutyric acid GABA neurotransmission pathogenesis hepatic encephalopathy mechanism GABA-ergic activity hepatic failure unclear recent studies animals encephalopathy due hepatic failure GABA-ergic neurotransmission presence elevated concentrations benzodiazepine agonists diazepam N-desmethyldiazepam METHODS RESULTS Samples frontal cortex autopsy patients hepatic encephalopathy acetaminophen-induced fulminant hepatic failure patients cardiovascular disease trauma None patients benzodiazepines Chromatographic analyses extracts samples peaks substances binding radiolabeled imidazobenzodiazepine flumazenil receptors Several peaks retention times Ultraviolet- mass-spectroscopic analysis peaks diazepam N-desmethyldiazepam patients fulminant hepatic failure groups brain concentrations normal substances binding flumazenil normal concentrations CONCLUSIONS Brain concentrations substances binding flumazenil receptors patients hepatic encephalopathy due hepatic failure origin substances unknown findings rational basis trials benzodiazepine-receptor antagonists management disorder 